Abstract
Forty-six patients with recurrent ovarian cancer were reoperated, and cancer samples for the subrenal capsule assay (SRCA) were collected from 23 of them, whereas this test was not done in the remaining 23 control patients. The SRCA was evaluable in 22 cases (96%). Taken together, no significant difference appeared in the 3 years' survival figures between the groups: seven of 22 patients (32%) with the evaluable SRCA and six of 23 control patients (26%) were alive. However, a further analysis of the data revealed that the SRCA guided the selection of chemotherapy only in 15 patients, whereas tumour samples were resistant to all cytostatics tested in six cases and toxic side-effects limited the clinical application of the test results in the remaining one case. Four of the 11 patients (36%) whose further chemotherapy was strictly chosen based on the SRCA and seven of the 24 patients (29%) whose treatment was based on physician's choice survived at least 3 years. Our conclusion is that the SRCA is of limited value in the selection of second-line chemotherapy in recurrent ovarian cancer.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Griffin T. W., Bogden A. E., Reich S. D., Antonelli D., Hunter R. E., Ward A., Yu D. T., Greene H. L., Costanza M. E. Initial clinical trials of the subrenal capsule assay as a predictor of tumor response to chemotherapy. Cancer. 1983 Dec 15;52(12):2185–2192. doi: 10.1002/1097-0142(19831215)52:12<2185::aid-cncr2820521202>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
- Hamburger A. W., Salmon S. E. Primary bioassay of human tumor stem cells. Science. 1977 Jul 29;197(4302):461–463. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
- Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
- Mäenpä J., Kangas L., Grönroos M. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I. Obstet Gynecol. 1985 Nov;66(5):708–713. [PubMed] [Google Scholar]
- Mäenpä J. Subrenal capsule assay as a predictor of clinical response of ovarian cancer to chemotherapy: Part II. Obstet Gynecol. 1985 Nov;66(5):714–718. [PubMed] [Google Scholar]
- Scheper R. J., Bulte J. W., Brakkee J. G., Quak J. J., van der Schoot E., Balm A. J., Meijer C. J., Broxterman H. J., Kuiper C. M., Lankelma J. Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycoprotein associated with multi-drug-resistance. Int J Cancer. 1988 Sep 15;42(3):389–394. doi: 10.1002/ijc.2910420314. [DOI] [PubMed] [Google Scholar]
- Selby P., Buick R. N., Tannock I. A critical appraisal of the "human tumor stem-cell assay". N Engl J Med. 1983 Jan 20;308(3):129–134. doi: 10.1056/NEJM198301203080304. [DOI] [PubMed] [Google Scholar]
- Stratton J. A., Kucera P. R., Micha J. P., Rettenmaier M. A., Braly P. S., Berman M. L., DiSaia P. J. The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experience. Gynecol Oncol. 1984 Nov;19(3):336–347. doi: 10.1016/0090-8258(84)90201-4. [DOI] [PubMed] [Google Scholar]
- Stratton J. A., Kucera P. R., Rettenmaier M. A., Dobashi K., Micha J. P., Braly P. S., Berman M. L., DiSaia P. J. Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatin. Gynecol Oncol. 1986 Nov;25(3):302–310. doi: 10.1016/0090-8258(86)90081-8. [DOI] [PubMed] [Google Scholar]
- Stratton J. A., Rettenmaier M. A., Kucera P. R., Berman M. L., DiSaia P. J. Concordance of combination and single agent chemosensitivity prediction in ovarian carcinoma using the subrenal capsule xenograft assay (SRCA). Gynecol Oncol. 1988 Jul;30(3):416–421. doi: 10.1016/0090-8258(88)90256-9. [DOI] [PubMed] [Google Scholar]
- Welander C. E., Homesley H. D., Jobson V. W. In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy? Am J Obstet Gynecol. 1983 Sep 15;147(2):188–195. doi: 10.1016/0002-9378(83)90114-x. [DOI] [PubMed] [Google Scholar]